- Home
- NVT vs DGX Comparison
NVT vs DGX Comparison
Compare NVT & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVT | DGX |
|---|---|---|
| Founded | 1903 | 1967 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.6B | 26.2B |
| IPO Year | 2017 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NVT | DGX |
|---|---|---|
| Price | $168.33 | $232.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 17 |
| Target Price | $204.44 | ★ $247.73 |
| AVG Volume (30 Days) | ★ 1.7M | 878.7K |
| Earning Date | 10-30-2026 | 10-22-2026 |
| Dividend Yield | 0.50% | ★ 1.47% |
| EPS Growth | ★ 118.78 | 13.78 |
| EPS | 2.18 | ★ 5.08 |
| Revenue | $3,893,100,000.00 | ★ $11,035,000,000.00 |
| Revenue This Year | $40.28 | $8.81 |
| Revenue Next Year | $17.86 | $4.70 |
| P/E Ratio | $76.05 | ★ $45.49 |
| Revenue Growth | ★ 29.51 | 11.78 |
| 52 Week Low | $93.22 | $171.18 |
| 52 Week High | $184.64 | $248.84 |
Technical Indicators
Market Signals| Indicator | NVT | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 61.27 | 43.23 |
| Support Level | $145.00 | $229.36 |
| Resistance Level | $176.79 | $248.02 |
| Average True Range (ATR) | 5.10 | 4.99 |
| MACD | 1.19 | -1.32 |
| Stochastic Oscillator | 91.15 | 22.75 |
Price Performance
Historical ComparisonAbout NVT nVent Electric plc
NVent is a leading global provider of electrical connection and protection solutions that touch a broad range of end markets, including infrastructure, industrial, commercial, and residential. NVent designs, manufactures, markets, installs, and services a portfolio of electrical enclosures and electrical fastening solutions. North America accounts for the majority of sales.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.